Endurant Capital Management LP Merck & Co., Inc. Transaction History

Endurant Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $26,175 - $28,529	-241 Reduced 0.49%	49,332 $5.69 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $7.87 Million - $8.78 Million	-76,430 Reduced 60.66%	49,573 $5.27 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $11 Million - $14.1 Million	126,003 New	126,003 $14 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $1.03 Million - $1.21 Million	-14,919 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $1.07 Million - $1.19 Million	14,919 New	14,919 $1.22 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $5.23 Million - $6.06 Million	-80,093 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $10.3 Million - $12.1 Million	-177,980 Reduced 68.96%	80,093 $5.68 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $4.34 Million - $5.1 Million	85,373 Added 49.43%	258,073 $15.7 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $3.39 Million - $3.94 Million	66,600 Added 62.77%	172,700 $9.41 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $5.48 Million - $6.54 Million	106,100	106,100 $5.97 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.